These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6813082)

  • 1. [A study on the therapeutic effect of rifamdin on pulmonary tuberculosis].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Apr; 5(2):74-7. PubMed ID: 6813082
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparison of therapeutic effectiveness between rifamdin-regimen and rifampicin-regimen in pulmonary tuberculosis].
    Lu Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Aug; 11(4):225-7, 255. PubMed ID: 3228902
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent report of short-term chemotherapy with rifamdin in pulmonary tuberculosis in rural areas].
    Qu SH; Meng ZR
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Aug; 7(4):208-9, 253. PubMed ID: 6549552
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitivity of Mycobacterium tuberculosis strains to antituberculosis drugs isolated at Dakar University Hospital, from 1987 to 1988.
    Cisse MF; Gaye A; Boye CS; Mboup S; Samb A; Vaillant V; Agius G; Dindinaud G; Castets M
    Bull Int Union Tuberc Lung Dis; 1989 Sep; 64(3):26-8. PubMed ID: 2516749
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)].
    Kekkaku; 1974 Jul; 49(7):207-15. PubMed ID: 4372439
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary resistance in 544 cases of pulmonary tuberculosis in the adult].
    Porven G; Piccolo R; Padin L
    Medicina (B Aires); 1979; 39(3):375-8. PubMed ID: 117276
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary drug resistance to antitubercular drugs in patients with pulmonary tuberculosis in the years 1978-1982].
    Janowiec M; Zwolska-Kwiek Z
    Pneumonol Pol; 1986 Apr; 54(4):140-3. PubMed ID: 3090521
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-resistance tuberculosis among the foreign-born in Canada.
    Can Commun Dis Rep; 2005 Feb; 31(4):46-52. PubMed ID: 15712449
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.
    Goldberg SV; Hanson D; Peloquin CA
    Clin Infect Dis; 2003 Aug; 37(4):607-8. PubMed ID: 12905149
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis].
    Rinder H
    Pneumologie; 1998 Feb; 52(2):91-2. PubMed ID: 9557056
    [No Abstract]   [Full Text] [Related]  

  • 11. Can studies of the early bactericidal activity of rifapentine tell us how to prevent acquired rifamycin-resistant relapse?
    Wallis RS
    Am J Respir Crit Care Med; 2005 Jul; 172(1):4-5. PubMed ID: 15980108
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alteration of permeability of bacterial envelope barrier in rifamdin-resistant Mycobacterium tuberculosis].
    Li XZ; Wang YS; He ZN
    Hua Xi Yi Ke Da Xue Xue Bao; 1988 Dec; 19(4):388-91. PubMed ID: 3149620
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 14. Tuberculosis. An overview.
    Clarkson EF
    J Intraven Nurs; 1999; 22(4):216-20. PubMed ID: 10476139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resistance of Mycobacterium tuberculosis strains isolated from patients to antituberculosis drugs].
    Sybirna RI; Iavors'ka GV
    Mikrobiol Z; 2001; 63(4):91-5. PubMed ID: 11692684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
    Tomioka H; Saito H
    Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic drug levels.
    Morehead RS
    South Med J; 2000 May; 93(5):507-10. PubMed ID: 10832953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effect of Ofloxacin on intractable pulmonary tuberculosis. Chest disease cooperative study unit of National Sanatoriums in Kinki District].
    Matsumoto T; Ikeda N; Kanetsuna F; Kita N; Ueda E; Yamazaki M; Kanai K; Sirai F; Iwagaki K; Takenaka K
    Kekkaku; 1988 Jun; 63(6):469-74. PubMed ID: 3172625
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of enviomycin (EVM) in pulmonary tuberculosis (author's transl)].
    Kuramitsu I; Ando K; Ito N; Kishimoto K; Murase Y; Matsumura H; Matsui O; Miki S; Ito T; Yanagawa T; Tanaka S; Sakai M; Takeuchi J; Yamamoto Y; Suzuki S; Sata K; Ohbori K; Horie E; Sakurai K; Mori T; Nagami T; Adachi S; Oda T; Yamaguchi K; Takehisa R
    Kekkaku; 1978 Apr; 53(4):269-73. PubMed ID: 661060
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of drug resistance of Mycobacterium tuberculosis by methods of proportions and absolute concentrations].
    Golyshevskaia VI; Sevast'ianova EV; Voronina GA
    Probl Tuberk; 2001; (3):51-3. PubMed ID: 11508236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.